Gold nanoparticle penetration and reduced metabolism in human skin by toluene

Pharmaceutical Research

Volumn 28, Issue 11, 2011, Pages 2931-2944

  Labouta, Hagar I ^a,b   Liu, David C ^c   Lin, Lynlee L ^c   Butler, Margaret K ^c   Grice, Jeffrey E ^c   Raphael, Anthony P ^c   Kraus, Tobias ^d   El Khordagui, Labiba K ^b   Soyer, H Peter ^c   Roberts, Michael S ^c,e   Schneider, Marc ^a   Prow, Tarl W ^c  

^a SAARLAND UNIVERSITY   (Germany)

^b ALEXANDRIA UNIVERSITY   (Egypt)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d INM LEIBNIZ INSTITUTE FOR NEW MATERIALS   (Germany)

^e UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

Confocal reflectance microscopy; Fluorescence lifetime; Multiphoton microscopy; Nanoparticle; Skin

Indexed keywords

GOLD NANOPARTICLE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; TOLUENE; WATER;

ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; EPILUMINESCENCE MICROSCOPY; FLUORESCENCE IMAGING; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN TISSUE; LIGHT SCATTERING; PRIORITY JOURNAL; SKIN PENETRATION; SKIN PERMEABILITY; SKIN SURFACE; STRATUM CORNEUM; THAWING; TRANSMISSION ELECTRON MICROSCOPY;

ADMINISTRATION, CUTANEOUS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; DRUG EVALUATION, PRECLINICAL; EPIDERMIS; GOLD; HUMANS; METAL NANOPARTICLES; NADP; PARTICLE SIZE; PERMEABILITY; SKIN; SKIN ABSORPTION; SOLVENTS; TOLUENE;

EID: 84856210640     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-011-0561-z     Document Type: Article

References (44)

1. Mooradia A. Photoluminescence of metals. Phys Rev Lett. 1969;22:185.
2. Prow TW, Chen X, Prow NA, Fernando GJ, Tan CS, Raphael AP, et al. Nanopatch-targeted skin vaccination against West Nile Virus and Chikungunya virus in mice. Small. 2010;6:1776-84.
3. Schneider M, Stracke F, Hansen S, Schaefer UF. Nanoparticles and their interactions with the dermal barrier. Dermatoendocrinol. 2009;1:197-206.
4. On regulatory aspects of nanomaterials. http://ec.europa.eu/health/ph- risk/commithttp://www.schneiderchildrenshospital.org/peds-html-fixed/peds/derm/ burns.htmtees/04-sccp/docs/sccp-o-123.pdf (accessed 15/09/2010).
5. Robertson TA, Sanchez WY, Roberts MS. Are commercially available nanoparticles safe when applied to the skin? J Biomed Nanotechnol. 2010;6:452-68.
6. Monteiro-Riviere NA, Tran CL. Nanotoxicology: characterization, dosing and health effects. New York: Informa Healthcare; 2007.
7. Prow TW, Grice JE, Lin LL, Faye R, Butler M, Becker W, et al. Nanoparticles and microparticles for skin drug delivery. Adv Drug Deliv Rev. 2011.
8. Küchler S, Abdel-Mottaleb M, Lamprecht A, Radowski MR, Haag R, Schäfer-Korting M. Influence of nanocarrier type and size on skin delivery of hydrophilic agents. Int J Pharm. 2009;377:169-72.
9. Rouse JG, Yang J, Ryman-Rasmussen JP, Barron AR, Monteiro- Riviere NA. Effects of mechanical flexion on the penetration of fullerene amino acid-derivatized peptide nanoparticles through skin. Nano Lett. 2007;7:155-60. (Pubitemid 46225845)
10. Mortensen LJ, Oberdorster G, Pentland AP, Delouise LA. In vivo skin penetration of quantum dot nanoparticles in the murine model: the effect of UVR. Nano Lett. 2008;8:2779-87.
11. Paliwal S, Menon GK, Mitragotri S. Low-frequency sonophoresis: ultrastructural basis for stratum corneum permeability assessed using quantum dots. J Invest Dermatol. 2006;126:1095-101.
12. Coulman SA, Anstey A, Gateley C, Morrissey A, McLoughlin P, Allender C, et al. Microneedle mediated delivery of nanoparticles into human skin. Int J Pharm. 2009;366:190-200.
13. Crosera M, Bovenzi M, Maina G, Adami G, Zanette C, Florio C, et al. Nanoparticle dermal absorption and toxicity: a review of the literature. Int Arch Occup Environ Health. 2009;82:1043-55.
14. Cevc G, Vierl U. Nanotechnology and the transdermal route: a state of the art review and critical appraisal. J Contr Release. 2010;141:277-99.
15. Prow TW, Grice JE, Lin LL, Faye R, Butler M, Becker W, et al. Nanoparticles and microparticles for skin drug delivery. Adv Drug Deliv Rev. 2011;63:470-91.
16. Roberts MS, Dancik Y, Prow TW, Thorling CA, Lin LL, Grice JE, et al. Non-invasive imaging of skin physiology and percutaneous penetration using fluorescence spectral and lifetime imaging with multiphoton and confocal microscopy. Eur J Pharm Biopharm. 2011;77:469-88.
17. Xia XR, Monteiro-Riviere NA, Riviere JE. Skin penetration and kinetics of pristine fullerenes (C60) topically exposed in industrial organic solvents. Toxicol Appl Pharmacol. 2010;242:29-37.
18. Harper M. Assessing workplace chemical exposures: the role of exposure monitoring. J Environ Monit. 2004;6:404-12. (Pubitemid 38716533)
19. Hoover MD, Stefaniak AB, Day GA, Geraci CL. Exposure assessment considerations for nanoparticles in the workplace. In: Monteiro-Riviereand NA, Tran CL, editors. Nanotoxicology: characterization, dosing and health effects. New York: Informa Healthcare; 2007. p. 71-83.
20. Riviereand JE, Brooks JD. Predicting skin permeability from complex chemical mixtures: dependency of quantitative structure permeation relationships on biology of skin model used. Toxicol Sci. 2011;119:224-32.
21. Riviereand JE, Brooks JD. Predicting skin permeability from complex chemical mixtures. Toxicol Appl Pharmacol. 2005;208:99-110 (Pubitemid 41377125)
22. Xia XR, Monteiro-Riviere NA, Riviere JE. Intrinsic biological property of colloidal fullerene nanoparticles (nC60): lack of lethality after high dose exposure to human epidermal and bacterial cells. Toxicol Lett. 2010;197:128-34.
23. Farrer RA, Butterfield FL, Chen VW, Fourkas JT. Highly efficient multiphoton-absorption-induced luminescence from gold nanoparticles. Nano Lett. 2005;5:1139-42. (Pubitemid 40925430)
24. Labouta HI, Kraus T, El-Khordagui LK, Schneider M. Combined multiphoton imaging-pixel analysis for semiquantitation of skin penetration of gold nanoparticles. Int J Pharmaceut. 2011;413:279-82.
25. Boyd GT, Yu ZH, Shen YR. Photoinduced Luminescence from the Noble-Metals and Its Enhancement on Roughened Surfaces. Phys Rev B. 1986;33:7923-36.
26. Yang Y, Qu Y, Lu X. Global gene expression analysis of the effects of gold nanoparticles on human dermal fibroblasts. J Biomed Nanotechnol. 2010;6:234-46.
27. Schaeublin NM, Braydich-Stolle LK, Schrand AM, Miller JM, Hutchison J, Schlager JJ, et al. Surface charge of gold nanoparticles mediates mechanism of toxicity. Nanoscale. 2011; 3:410-20.
28. Lu S, Xia D, Huang G, Jing H, Wang Y, Gu H. Concentration effect of gold nanoparticles on proliferation of keratinocytes. Colloids Surf B Biointerfaces. 2010;81:406-11.
29. Larese Filon F, Crosera M, Adami G, Bovenzi M, Rossi F, Maina G. Human skin penetration of gold nanoparticles through intact and damaged skin. Nanotoxicology. 2011. doi:10.3109/17435390.2010.551428.
30. Turkevich J, Stevenson PC, Hillier J. A study of the nucleation and growth processes in the synthesis of colloidal gold. discuss, Faraday Soc. 1951;55-57.
31. Zheng N, Fan J, Stucky GD. One-step one-phase synthesis of monodisperse noble-metallic nanoparticles and their colloidal crystals. J Am Chem Soc. 2006;128:6550-1.
32. Wagner H, Kostka KH, Adelhardt W, Schaefer UF. Effects of various vehicles on the penetration of flufenamic acid into human skin. Eur J Pharm Biopharm. 2004;58:121-9. (Pubitemid 38781012)
33. Lin LL, Grice JE, Butler MK, Zvyagin AV, Becker W, Robertson TA, et al. Time-Correlated Single Photon Counting for Simultaneous Monitoring of Zinz Oxide Nanoparticles and NAD(P)H in Intact and Barrier Disrupted Volunteer Skin. Pharm Res. 2011. doi:10.1007/s11095-011-0515-5.
34. Schneider G, Decher G. Functional core/shell nanoparticles via layer-by-layer assembly. Investigation of the experimental parameters for controlling particle aggregation and for enhancing dispersion stability. Langmuir. 2008;24:1778-89. (Pubitemid 351500932)
35. Bird DK, Yan L, Vrotsos KM, Eliceiri KW, Vaughan EM, Keely PJ, et al. Metabolic mapping of MCF10A human breast cells via multiphoton fluorescence lifetime imaging of the coenzyme NADH. Cancer Res. 2005;65:8766-73. (Pubitemid 41377365)
36. Sanchez WY, Prow TW, Sanchez WH, Grice JE, Roberts MS. Analysis of the metabolic deterioration of ex vivo skin from ischemic necrosis through the imaging of intracellular NAD(P)H by multiphoton tomography and fluorescence lifetime imaging microscopy. J Biomed Opt. 2010;15:046008.
37. Godinand B, Touitou E. Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models. Adv Drug Deliv Rev. 2007;59:1152-61. (Pubitemid 47615204)
38. Okyar A, Nuriyev M, Yildiz A, Pala-Kara Z, Ozturk N, Kaptan E. The effect of terpenes on percutaneous absorption of tiaprofenic acid gel. Arch Pharm Res. 2010;33:1781-8.
39. Sonavane G, Tomoda K, Sano A, OhshimaH, TeradaH,MakinoK. In vitro permeation of gold nanoparticles through rat skin and rat intestine: effect of particle size. Colloid Surface B. 2008;65:1-10.
40. Prow TW, Monteiro-Riviere NA, Inman AO, Grice JE, Chen X, Zhao X, et al. Quantum dot penetration into viable human skin. Nanotoxicology. 2011.
41. Parfenov AS, Salnikov V, Lederer WJ, Lukyanenko V. Aqueous diffusion pathways as a part of the ventricular cell ultrastructure. Biophys J. 2006;90:1107-19.
42. Lacerda SH, Park JJ, Meuse C, Pristinski D, Becker ML, Karim A, et al. Interaction of gold nanoparticles with common human blood proteins. ACS Nano. 2010;4:365-79.
43. Westerand RC, Maibach HI. Percutaneous absorption of topical corticosteroids. Curr Probl Dermatol. 1993;21:45-60.
44. Wester RC, Melendres J, Sedik L, Maibach H, Riviere JE. Percutaneous absorption of salicylic acid, theophylline, 2, 4- dimethylamine, diethyl hexyl phthalic acid, and p-aminobenzoic acid in the isolated perfused porcine skin flap compared to man in vivo. Toxicol Appl Pharmacol. 1998;151:159-65. (Pubitemid 28406663)